Progyny, Inc. Capital Expenditures
Progyny, Inc. (PGNY) reported Capital Expenditures of $12.57 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-07
- Progyny, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $6.22M, a 18.03% increase year-over-year.
- Progyny, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $6.35M, a 123.25% increase year-over-year.
- Progyny, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $5.61M, a 196.25% increase year-over-year.
- Progyny, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $4.68M, a 161.09% increase year-over-year.
- Progyny, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $18.41M, a 240.61% increase from fiscal 2024.
- Progyny, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $5.41M, a 48.33% increase from fiscal 2023.
- Progyny, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $3.64M, a 12.43% increase from fiscal 2022.
- Progyny, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $3.24M, a 52.23% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $12.57M 10-Q · filed 2026-08-07 | $18.18M derived: sum of 3 quarters · filed 2026-08-07 | $22.86M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $6.35M 10-Q · filed 2026-05-08 | $11.96M derived: sum of 2 quarters · filed 2026-05-08 | $16.64M derived: sum of 3 quarters · filed 2026-05-08 | $21.91M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $5.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $10.30M derived: sum of 2 quarters · filed 2026-02-27 | $15.57M derived: sum of 3 quarters · filed 2026-08-07 | $18.41M 10-K · filed 2026-02-27 |
| 2025-09-30 | $4.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $9.95M derived: sum of 2 quarters · filed 2026-08-07 | $12.80M 10-Q · filed 2025-11-07 | $14.69M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $5.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $8.11M 10-Q · filed 2026-08-07 | $10.01M derived: sum of 3 quarters · filed 2026-08-07 | $11.80M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $2.84M 10-Q · filed 2026-05-08 | $4.74M derived: sum of 2 quarters · filed 2026-05-08 | $6.53M derived: sum of 3 quarters · filed 2026-05-08 | $7.40M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.69M derived: sum of 2 quarters · filed 2026-02-27 | $4.55M derived: sum of 3 quarters · filed 2026-02-27 | $5.41M 10-K · filed 2026-02-27 |
| 2024-09-30 | $1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $2.66M derived: sum of 2 quarters · filed 2025-11-07 | $3.51M 10-Q · filed 2025-11-07 | $4.19M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $866.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $1.72M 10-Q · filed 2025-08-08 | $2.40M derived: sum of 3 quarters · filed 2026-02-27 | $3.35M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $850.00K 10-Q · filed 2025-05-09 | $1.53M derived: sum of 2 quarters · filed 2026-02-27 | $2.48M derived: sum of 3 quarters · filed 2026-02-27 | $3.24M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $681.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.63M derived: sum of 2 quarters · filed 2026-02-27 | $2.39M derived: sum of 3 quarters · filed 2026-02-27 | $3.64M 10-K · filed 2026-02-27 |
| 2023-09-30 | $953.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.71M derived: sum of 2 quarters · filed 2024-11-12 | $2.96M 10-Q · filed 2024-11-12 | $3.68M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $759.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $2.01M 10-Q · filed 2024-08-07 | $2.73M derived: sum of 3 quarters · filed 2025-03-03 | $3.97M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $1.25M 10-Q · filed 2024-05-10 | $1.97M derived: sum of 2 quarters · filed 2025-03-03 | $3.21M derived: sum of 3 quarters · filed 2025-03-03 | $3.70M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $721.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $1.96M derived: sum of 2 quarters · filed 2025-03-03 | $2.45M derived: sum of 3 quarters · filed 2025-03-03 | $3.24M 10-K · filed 2025-03-03 |
| 2022-09-30 | $1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.73M derived: sum of 2 quarters · filed 2023-11-08 | $2.52M 10-Q · filed 2023-11-08 | $3.13M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $490.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $1.28M 10-Q · filed 2023-08-04 | $1.89M derived: sum of 3 quarters · filed 2024-02-29 | $2.61M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $790.00K 10-Q · filed 2023-05-09 | $1.40M derived: sum of 2 quarters · filed 2024-02-29 | $2.12M derived: sum of 3 quarters · filed 2024-02-29 | $2.55M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $612.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.33M derived: sum of 2 quarters · filed 2024-02-29 | $1.76M derived: sum of 3 quarters · filed 2024-02-29 | $2.13M 10-K · filed 2024-02-29 |
| 2021-09-30 | $718.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $1.15M derived: sum of 2 quarters · filed 2022-11-04 | $1.52M 10-Q · filed 2022-11-04 | $1.61M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $430.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $799.00K 10-Q · filed 2022-08-05 | $896.00K derived: sum of 3 quarters · filed 2023-03-01 | $1.04M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $369.00K 10-Q · filed 2022-05-06 | $466.00K derived: sum of 2 quarters · filed 2023-03-01 | $615.00K derived: sum of 3 quarters · filed 2023-03-01 | $713.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $246.00K derived: sum of 2 quarters · filed 2023-03-01 | $344.00K derived: sum of 3 quarters · filed 2023-03-01 | $1.04M 10-K · filed 2023-03-01 |
| 2020-09-30 | $149.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $247.00K derived: sum of 2 quarters · filed 2021-11-08 | $940.00K 10-Q · filed 2021-11-08 | $3.22M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $98.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $791.00K 10-Q · filed 2021-08-06 | $3.07M derived: sum of 3 quarters · filed 2022-03-01 | $3.49M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $693.00K 10-Q · filed 2021-05-07 | $2.97M derived: sum of 2 quarters · filed 2022-03-01 | $3.39M derived: sum of 3 quarters · filed 2022-03-01 | $3.52M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $2.70M derived: sum of 2 quarters · filed 2022-03-01 | $2.83M derived: sum of 3 quarters · filed 2022-03-01 | $2.96M 10-K · filed 2022-03-01 |
| 2019-09-30 | $420.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $553.00K derived: sum of 2 quarters · filed 2020-11-06 | $678.00K 10-Q · filed 2020-11-06 | $856.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $258.00K 10-Q · filed 2020-08-07 | $436.00K derived: sum of 3 quarters · filed 2021-03-01 | |
| 2019-03-31 | $125.00K 10-Q · filed 2020-05-14 | $303.00K derived: sum of 2 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $579.00K 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $401.00K 10-Q · filed 2019-12-06 | |||
| 2017-12-31 | $612.00K 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |